Brouwers JR - Search Results

1

Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study.

Vonkeman HE, Braakman-Jansen LM, Klok RM, Postma MJ, Brouwers JR, van de Laar MA. Vonkeman HE, et al. Among authors: brouwers jr. Arthritis Res Ther. 2008;10(6):R144. doi: 10.1186/ar2577. Epub 2008 Dec 16. Arthritis Res Ther. 2008. PMID: 19077318 Free PMC article.

2

Incremental cost-effectiveness of cyclooxygenase 2-selective versus nonselective nonsteroidal anti-inflammatory drugs in a cohort of coumarin users: a pharmacoeconomic analysis linked to a case-control study.

Knijff-Dutmer EA, Postma MJ, van der Palen J, Brouwers JR, van de Laar MA. Knijff-Dutmer EA, et al. Among authors: brouwers jr. Clin Ther. 2004 Jul;26(7):1160-7. doi: 10.1016/s0149-2918(04)90188-9. Clin Ther. 2004. PMID: 15336481

3

Understanding the NSAID related risk of vascular events.

Vonkeman HE, Brouwers JR, van de Laar MA. Vonkeman HE, et al. Among authors: brouwers jr. BMJ. 2006 Apr 15;332(7546):895-8. doi: 10.1136/bmj.332.7546.895. BMJ. 2006. PMID: 16613964 Free PMC article. Review. No abstract available.

4

Allele variants of the cytochrome P450 2C9 genotype in white subjects from The Netherlands with serious gastroduodenal ulcers attributable to the use of NSAIDs.

Vonkeman HE, van de Laar MA, van der Palen J, Brouwers JR, Vermes I. Vonkeman HE, et al. Among authors: brouwers jr. Clin Ther. 2006 Oct;28(10):1670-6. doi: 10.1016/j.clinthera.2006.10.019. Clin Ther. 2006. PMID: 17157122

5

Direct medical costs of serious gastrointestinal ulcers among users of NSAIDs.

Vonkeman HE, Klok RM, Postma MJ, Brouwers JR, van de Laar MA. Vonkeman HE, et al. Among authors: brouwers jr. Drugs Aging. 2007;24(8):681-90. doi: 10.2165/00002512-200724080-00005. Drugs Aging. 2007. PMID: 17702536

6

A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.

van Hout BA, Klok RM, Brouwers JR, Postma MJ. van Hout BA, et al. Among authors: brouwers jr. Clin Ther. 2003 Feb;25(2):635-46. doi: 10.1016/s0149-2918(03)80101-7. Clin Ther. 2003. PMID: 12749518

7

Pharmacoeconomics of gastrointestinal drug utilisation prior and post Helicobacter pylori eradication.

Klok RM, van der Veen WJ, van der Werf GT, van den Berg PB, Brouwers JR, Postma MJ. Klok RM, et al. Among authors: brouwers jr. Helicobacter. 2004 Feb;9(1):87-91. doi: 10.1111/j.1083-4389.2004.00202.x. Helicobacter. 2004. PMID: 15156909

8

Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.

Klok RM, Arents NL, de Vries R, Thijs JC, Brouwers JR, Kleibeuker JH, Postma MJ. Klok RM, et al. Among authors: brouwers jr. Clin Ther. 2005 Oct;27(10):1647-57. doi: 10.1016/j.clinthera.2005.10.011. Clin Ther. 2005. PMID: 16330302

9

Cost considerations in the treatment of colorectal cancer.

Jansman FG, Postma MJ, Brouwers JR. Jansman FG, et al. Among authors: brouwers jr. Pharmacoeconomics. 2007;25(7):537-62. doi: 10.2165/00019053-200725070-00002. Pharmacoeconomics. 2007. PMID: 17610336 Review.

10

Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health.

de Vries R, Klok RM, Brouwers JR, Postma MJ. de Vries R, et al. Among authors: brouwers jr. Vaccine. 2009 Feb 5;27(6):846-52. doi: 10.1016/j.vaccine.2008.11.081. Epub 2008 Dec 11. Vaccine. 2009. PMID: 19084566 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters